Abstract:Objective To study the effects and mechanisms of tetramethylpyrazine (TMP) on tumor necrosis factor-α (TNF-α)-induced inflammatory injury in human coronary artery endothelial cells (HCAEC). Methods HCAEC were randomly divided into four groups: the control group (no treatment), the model group (treated with TNF-α, 50 ng/mL for 24 hours), the TMP group (pre-treated with TMP, 80 μg/mL for 12 hours followed by TNF-α treatment for 24 hours), and the SIRT1 inhibitor group (pre-treated with TMP and the specific SIRT1 inhibitor EX527 for 12 hours followed by TNF-α treatment for 24 hours). Cell viability was assessed using the CCK-8 method, lactate dehydrogenase (LDH) activity was measured using an LDH assay kit, reactive oxygen species (ROS) levels were observed using DCFH-DA staining, expression of pyroptosis-related proteins was detected by Western blot, and SIRT1 expression was analyzed using immunofluorescence staining. Results Compared to the control group, the model group showed decreased cell viability, increased LDH activity, ROS level and expression of pyroptosis-related proteins, and decreased SIRT1 expression (P<0.05). Compared to the model group, the TMP group exhibited increased cell viability, decreased LDH activity, ROS level and expression of pyroptosis-related proteins, and increased SIRT1 expression (P<0.05). In comparison to the TMP group, the SIRT1 inhibitor group showed decreased cell viability, increased LDH activity, ROS level and expression of pyroptosis-related proteins, and decreased SIRT1 expression (P<0.05). Conclusions TMP may attenuate TNF-α-induced inflammatory injury in HCAEC, which is associated with the inhibition of pyroptosis and activation of the SIRT1 signaling pathway.
CHEN Lu-Ping,YANG Yi-Tong,ZHAO Miao-Miao et al. Mechanism of tetramethylpyrazine attenuates inflammatory injury in endothelial cells by activating the SIRT1 signaling pathway[J]. CJCP, 2024, 26(9): 967-973.
Liu J, Yan Y, Zheng D, et al. Inhibiting microRNA-200a-3p attenuates pyroptosis via targeting the SIRT1/NF-κB/NLRP3 pathway in H2O2-induced HAEC[J]. Aging (Albany NY), 2023, 15(20): 11184-11200. PMID: 37874693. PMCID: PMC10637806. DOI: 10.18632/aging.205121.
Yang Y, Wang N, Wang Z, et al. Protective role of forsythoside B in Kawasaki disease-induced cardiac injury: inhibition of pyroptosis via the SIRT1-NF-κB-p65 signaling pathway[J]. Chem Biol Interact, 2024, 392: 110953. PMID: 38471628. DOI: 10.1016/j.cbi.2024.110953.
Ding Y, Peng Y, Wu H, et al. The protective roles of liraglutide on Kawasaki disease via AMPK/mTOR/NF-κB pathway[J]. Int Immunopharmacol, 2023, 117: 110028. PMID: 36934674. DOI: 10.1016/j.intimp.2023.110028.
Liu Y, Tan Y, Cao G, et al. Bergenin alleviates myocardial ischemia-reperfusion injury via SIRT1 signaling[J]. Biomed Pharmacother, 2023, 158: 114100. PMID: 36538860. DOI: 10.1016/j.biopha.2022.114100.
Stock AT, Jama HA, Hansen JA, et al. TNF and IL-1 play essential but temporally distinct roles in driving cardiac inflammation in a murine model of Kawasaki disease[J]. J Immunol, 2019, 202(11): 3151-3160. PMID: 30996002. DOI: 10.4049/jimmunol.1801593.
Guo M, Liu Y, Shi D. Cardiovascular actions and therapeutic potential of tetramethylpyrazine (active component isolated from Rhizoma Chuanxiong): roles and mechanisms[J]. Biomed Res Int, 2016, 2016: 2430329. PMID: 27314011. PMCID: PMC4893570. DOI: 10.1155/2016/2430329.
Shao H, Zhao L, Chen F, et al. Efficacy of ligustrazine injection as adjunctive therapy for angina pectoris: a systematic review and meta-analysis[J]. Med Sci Monit, 2015, 21: 3704-3715. PMID: 26615387. PMCID: PMC4671452. DOI: 10.12659/msm.895362.
Singh V, Ubaid S. Role of silent information regulator 1 (SIRT1) in regulating oxidative stress and inflammation[J]. Inflammation, 2020, 43(5): 1589-1598. PMID: 32410071. DOI: 10.1007/s10753-020-01242-9.